Skip to main content
. 2010 Jul 5;28(34):5591–5596. doi: 10.1016/j.vaccine.2010.06.031

Table 2.

Pneumonia and ILI incidence rates and SP carriage rates by platoon.

Platoon (# of companies included)a Living setting Pneumonia attack rateb Combined ILI + pneumonia attack ratec Pneumococcal carriage among controlsd Sp5 carriage among controlse Ratio of pneumonia attack rates and Sp5 carriage rates Other serotypes (non-Sp5) carried
A (3/3) 5–8 per room 4/86 (4.7%) 8/86 (9.3%) 5/14 (35.7%) 3/14 (21.4%) 1:4.6 23F (1), 9V (1), 6B (1)
C (3/4) 7–8 per room 2/97 (2.1%) 6/97 (6.2%) 10/17 (58.8%) 2/17 (11.8%) 1:5.7 10B (3), 15B/C (2), 3 (2), non-typable (1)
D (2/3) 8 per room 1/49 (2%) 4/49 (8.1%) 4/22 (18.2%) 1/22 (4.5%) 1:2.2 16F (1), non-typable (2)
H (3/3) 10–12 per tent 5/91 (5.5%) 7/91 (7.7%) 34/63 (54%) 22/63 (36.5%) 1:6.6 3 (2), 15B/C (1), 15C (1), 17F (1), 18C (1), 23F(3), 35B (2)
4 platoons Summary 12/323 (3.7%) 13/323 (7.7%) 53/116 (45.7%) 29/116 (25%) 1:6.7
Overall-all recruits 15/596 (2.5%) 34/596 (5.7%) 55/124 (44.4%) 30/124 (24.2%) 1:7.8
a

Selected 4 of 6 platoon in which 5 or more recruits were sampled, and selected companies with at least 1 cases of pneumonia or ILI.

b

Number of pneumonia cases/total platoon recruits (%).

c

Number of ILI and pneumonia cases/total platoon recruits (%).

d

Number of pneumococcal carriers/total controls tested (%).

e

Number of Sp5 carriers/total controls tested (%).